AAAAAA

   
Results: 1-12 |
Results: 12
Use of ICHOR-platelet works to assess platelet function in patients treated with GP IIb/IIIa inhibitors
Authors: Lakkis, NM George, S Thomas, E Ali, M Guyer, K Carville, D
Citation: Nm. Lakkis et al., Use of ICHOR-platelet works to assess platelet function in patients treated with GP IIb/IIIa inhibitors, CATHET C IN, 53(3), 2001, pp. 346-351
Comparison of ethanol septal reduction therapy with surgical myectomy for the treatment of hypertrophic obstructive cardiomyopathy
Authors: Nagueh, SF Ommen, SR Lakkis, NM Killip, D Zoghbi, WA Schaff, HV Danielson, GK Quinones, MA Tajik, AJ Spencer, WH
Citation: Sf. Nagueh et al., Comparison of ethanol septal reduction therapy with surgical myectomy for the treatment of hypertrophic obstructive cardiomyopathy, J AM COL C, 38(6), 2001, pp. 1701-1706
Echocardiographic insights into the mechanisms of relief of left ventricular outflow tract obstruction after nonsurgical septal reduction therapy in patients with hypertrophic obstructive cardiomyopathy
Authors: Flores-Ramirez, R Lakkis, NM Middleton, KJ Killip, D Spencer, WH Nagueh, SF
Citation: R. Flores-ramirez et al., Echocardiographic insights into the mechanisms of relief of left ventricular outflow tract obstruction after nonsurgical septal reduction therapy in patients with hypertrophic obstructive cardiomyopathy, J AM COL C, 37(1), 2001, pp. 208-214
Decreased expression of turner necrosis factor-alpha and regression of hypertrophy after nonsurgical septal reduction therapy for patients with hypertrophic obstructive cardiomyopathy
Authors: Nagueh, SF Stetson, SJ Lakkis, NM Killip, D Perez-Verdia, A Entman, ML Spencer, WH Torre-Amione, G
Citation: Sf. Nagueh et al., Decreased expression of turner necrosis factor-alpha and regression of hypertrophy after nonsurgical septal reduction therapy for patients with hypertrophic obstructive cardiomyopathy, CIRCULATION, 103(14), 2001, pp. 1844-1850
Regression of left ventricular hypertrophy after nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy
Authors: Mazur, W Nagueh, SF Lakkis, NM Middleton, KJ Killip, D Roberts, R Spencer, WH
Citation: W. Mazur et al., Regression of left ventricular hypertrophy after nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy, CIRCULATION, 103(11), 2001, pp. 1492-1496
Nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy: One-year follow-up
Authors: Lakkis, NM Nagueh, SF Dunn, JK Killip, D Spencer, WH
Citation: Nm. Lakkis et al., Nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy: One-year follow-up, J AM COL C, 36(3), 2000, pp. 852-855
Changes in left ventricular filling and left atrial function six months after nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy
Authors: Nagueh, SF Lakkis, NM Middleton, KJ Killip, D Zoghbi, WA Quinones, MA Spencer, WH
Citation: Sf. Nagueh et al., Changes in left ventricular filling and left atrial function six months after nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy, J AM COL C, 34(4), 1999, pp. 1123-1128
Chimeric 7E3 Fab (ReoPro) decreases detectable CD11b on neutrophils from patients undergoing coronary angioplasty
Authors: Mickelson, JK Ali, MN Kleiman, NS Lakkis, NM Chow, TW Hughes, BJ Smith, CW
Citation: Jk. Mickelson et al., Chimeric 7E3 Fab (ReoPro) decreases detectable CD11b on neutrophils from patients undergoing coronary angioplasty, J AM COL C, 33(1), 1999, pp. 97-106
Changes in left ventricular diastolic function 6 months after nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy
Authors: Nagueh, SF Lakkis, NM Middleton, KJ Killip, D Zoghbi, WA Quinones, MA Spencer, WH
Citation: Sf. Nagueh et al., Changes in left ventricular diastolic function 6 months after nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy, CIRCULATION, 99(3), 1999, pp. 344-347
Doppler estimation of left ventricular filling pressures in patients with hypertrophic cardiomyopathy
Authors: Nagueh, SF Lakkis, NM Middleton, KJ Spencer, WH Zoghbi, WA Quinones, MA
Citation: Sf. Nagueh et al., Doppler estimation of left ventricular filling pressures in patients with hypertrophic cardiomyopathy, CIRCULATION, 99(2), 1999, pp. 254-261
Tirofiban for cocaine-induced coronary artery thrombosis - A novel therapeutic approach
Authors: Frangogiannis, NG Farmer, JA Lakkis, NM
Citation: Ng. Frangogiannis et al., Tirofiban for cocaine-induced coronary artery thrombosis - A novel therapeutic approach, CIRCULATION, 100(18), 1999, pp. 1939-1939
Transcatheter alcohol septal ablation for hypertrophic obstructive cardiomyopathy - Response
Authors: Spencer, WH Lakkis, NM Nagueh, SF Kleiman, NS Killip, D He, ZX Verani, MS Roberts, R
Citation: Wh. Spencer et al., Transcatheter alcohol septal ablation for hypertrophic obstructive cardiomyopathy - Response, CIRCULATION, 100(11), 1999, pp. 1252-1252
Risultati: 1-12 |